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Abstract  
Recent evidence suggests that lifestyle factors influence the association between the 
Melanocortin 4 receptor (MC4R) and Transcription Factor 7-Like 2 (TCF7L2) gene variants 
and cardio-metabolic traits in several populations; however, the available research is limited 
among the Asian Indian population. Hence, the present study examined whether the 
association between the MC4R single nucleotide polymorphism (SNP) (rs17782313) and two 
SNPs of the TCF7L2 gene (rs12255372 and rs7903146) and cardio-metabolic traits is 
modified by dietary factors and physical activity. This cross sectional study included a 
random sample of normal glucose tolerant (NGT) (n=821) and participants with type 2 
diabetes (T2D) (n=861) recruited from the urban part of the Chennai Urban Rural 
Epidemiology Study (CURES). A validated food frequency questionnaire (FFQ) was used for 
dietary assessment and self-reported physical activity measures were collected. The threshold 
for significance was set at P=0.00023 based on Bonferroni correction for multiple testing 
[(0.05/210 (3 SNPs x 14 outcomes x 5 lifestyle factors)]. After Bonferroni correction, there 
was a significant interaction between the TCF7L2 rs12255372 SNP and fat intake (g/day) 
(Pinteraction=0.0001) on high-density lipoprotein cholesterol (HDL-C), where the ‘T’ allele 
carriers in the lowest tertile of total fat intake had higher HDL-C (P=0.008) and those in the 
highest tertile (P=0.017) had lower HDL-C compared to the GG homozygotes. In a secondary 
analysis of SNPs with the subtypes of fat, there was also a significant interaction between the 
SNP rs12255372 and polyunsaturated fatty acids (PUFA, g/day) (Pinteraction<0.0001) on HDL-
C, where the minor allele carriers had higher HDL-C in the lowest PUFA tertile (P=0.024) 
and those in the highest PUFA tertile had lower HDL-C (P=0.028) than GG homozygotes. In 
addition, a significant interaction was also seen between TCF7L2 SNP rs12255372 and fibre 
intake (g/day) on HDL-C (Pinteraction<0.0001). None of the other interactions between the 
SNPs and lifestyle factors were statistically significant after correction for multiple testing. 
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Our findings indicate that the association between TCF7L2 SNP rs12255372 and HDL-C 
may be modified by dietary fat intake in this Asian Indian population.  
 
Keywords: TCF7L2, MC4R, CURES, Asian Indian, Obesity, Type 2 diabetes, HDL-C, Fat 
intake, PUFA, Dietary fibre 
 
Abbreviations: MC4R: Melanocortin 4 receptor; TCF7L2: Transcription factor 7 like 2; 
CURES: Chennai Urban Rural Epidemiological Study; NGT: Normal glucose tolerance; 
T2D: Type 2 diabetes.  
 
 
5 
 
Introduction 
Genetic variants, unhealthy dietary intake, physical inactivity and their multiple 
interactions are considered to be contributory factors to the development of obesity and type 
2 diabetes (T2D) [1-3]. After China, India has the highest number of people with T2D in the 
world and according to the Indian Council of Medical Research – INdia DIABetes (ICMR – 
INDIAB) study, T2D cases have reached 62.4 million and 77.2 million people are pre-
diabetic [4]. Furthermore, obesity and T2D are risk factors for non-communicable diseases 
(NCDs) such as cardiovascular disease (CVD) and it is estimated that India will have the 
highest rate of CVD mortality in the world [5]. Asian Indians have different biochemical 
characteristics from other populations from birth, often referred to as the ‘Asian Indian 
Phenotype’ which consists of increased visceral fat and waist circumference, 
hyperinsulinemia and insulin resistance [6].  
The association between several genes and metabolic diseases has been identified by 
the candidate gene approach and genome-wide scans; to date, besides the FTO (Fat mass and 
obesity associated) gene, the strongest obesity risk loci known so far [1, 3, 7, 8], two 
commonly studied candidates for obesity and T2D have been the Melanocortin 4 Receptor 
(MC4R) and Transcription Factor 7-Like 2 (TCF7L2) genes. Strong association between the 
MC4R gene and risk of obesity was identified by a genome-wide association (GWAS) study 
[9] whereas the association between the Transcription Factor 7-Like 2 (TCF7L2) gene and 
risk of T2D was identified by a genome wide linkage study [10]. MC4R is expressed in the 
hypothalamus within the brain and therefore it is suggested that it contributes to body weight 
regulation by its effect on food intake and energy homeostasis [11]. A strong association was 
identified between MC4R rs17782313 genetic variant and risk of obesity in a European 
population [12] which was then replicated in other populations [13-15], including Asian 
Indians [16]. The TCF7L2 gene is involved in the Wnt signalling pathway where it affects the 
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expression of pro-glucagon and consequently blood glucose regulation [10]. In addition, the 
effect of pro-glucagon on Glucagon-like peptide 1 (GLP-1) also influences blood glucose 
regulation with insulin [17]. Decreased insulin secretion and increased glucose production in 
the liver is suggested to be the result of over expression of the TCF7L2 gene [18]. A couple 
of studies [19, 20] have shown strong associations between the two TCF7L2 single nucleotide 
polymorphisms (SNPs) (rs7903146, rs12255372) and risk of T2D among Asian Indians 
living in India, in addition to a meta-analysis [17]. 
In recent years, several studies have examined whether the association between the 
genetic variants of MC4R and TCF7L2 genes and cardio-metabolic traits is modified by 
lifestyle factors such as diet and physical activity in various populations [21-25], however 
there are no studies to date among Asian Indians [26]. Whilst most studies in European 
populations found no significant interactions between the MC4R SNP rs17782313 and dietary 
factors on obesity traits [11, 22, 23], a prospective cohort study reported significant 
interactions between the SNP and fat and protein intake on body mass index (BMI) and risk 
of T2D [27]. Similarly some studies identified significant interactions between TCF7L2 SNPs 
and fibre and fat intake on T2D[28-30]; however there were discrepancies between the 
studies which could be due to differences in sample size, study design, dietary assessment 
and genetic heterogeneity. The objectives of this paper were to determine whether the MC4R 
SNP rs17782313 and TCF7L2 SNPs (rs7903146, rs12255372) were associated with cardio-
metabolic traits and whether the association was modified by diet and physical activity in a 
sample size of up to 1,682 adults from the Chennai Urban Rural Epidemiology Study 
(CURES).  
 
Materials and Methods 
Study participants 
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A random, unrelated sample of normal glucose tolerant (NGT) (n=821) and T2D (n= 
861) participants were recruited from the urban part of the cross sectional Chennai Urban 
Rural Epidemiology Study (CURES) which included 26,001 individuals in total as a 
representative sample of Chennai city. Full details of the methodology have been explained 
previously [31]. Briefly 26,001 adult subjects (>20 years of age) were recruited in Phase 1 of 
CURES using a systematic random sampling method covering the whole Chennai city. This 
included 1,529 ‘self-reported’ diabetic subjects. In Phase 2, all self-reported or ‘known 
diabetic’ subjects were invited to our centre for detailed studies of whom 1382 responded 
(response rate: 90.4%). In Phase 3, every tenth subject from Phase 1, excluding those with 
self-reported diabetes, underwent an oral glucose tolerance test (OGTT). Subjects who had 
fasting plasma glucose <5.6 mmol/l (100mg/dl) and 2 hr plasma glucose value 7.8 mmol/l 
(140mg/dl) were categorized as having NGT [32]. Those who were confirmed by OGTT to 
have 2 hr plasma glucose value 11.1 mmol/l (200 mg/dl) were classed as ‘newly detected 
diabetic subjects’ (n=222).For the present study, the NGT subjects were selected from Phase 
3 and subjects with T2D which included ‘known diabetic’ and ‘newly detected diabetic’ 
subjects were selected from Phase 2 and Phase 3 of the Chennai Urban Rural Epidemiology 
Study. The Madras Diabetes Research Foundation Institutional Ethics Committee granted the 
ethical approval and informed consent was obtained from the study participants. 
 
Anthropometric and biochemical measurements 
Weight, height and waist circumference were measured by standard methods. The 
BMI calculation was based on the body weight (kg) divided by the square of body height (m). 
Roche Diagnostics (Mannheim) provided the equipments in order to be able to carry out the 
biochemical analyses on a Hitachi-912 Auto Analyzer (Hitachi, Mannheim, Germany)(8). 
Fasting plasma glucose, serum cholesterol, serum triglycerides (TG) and high-density 
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lipoprotein cholesterol were measured by glucose oxidase-peroxidase, cholesterol oxidase-
phenol-4-amino-antipyrene peroxidase, glycerol phosphatase oxidase-phenol-4-amino-
antipyrene peroxidise and polyethylene glycol-pretreated enzyme methods respectively(8). 
The Friedewald formula was used to estimate low-density lipoprotein cholesterol 
concentrations [33]. Glycated haemoglobin (HbA1c) and serum insulin were determined by 
high-performance liquid chromatography (HPLC) on a Variant instrument (Bio-Rad, 
Hercules, CA, USA) and an enzyme-linked immunosorbent assay (Dako, Glostrup, Denmark) 
respectively [8].  
 
Assessment of dietary intake and physical activity 
A validated, interviewer administered semi-quantitative food frequency questionnaire 
(FFQ) [34] consisting of a list of 222 different foods was used in order to evaluate dietary 
intake for the previous year including macronutrient and total energy intake. Frequencies (per 
day, week, month, year, never) and portion sizes were estimated by the participants with the 
help of visual aids of measurement equipments and food sizes. Daily average food and 
nutrient intake was calculated by the EpiNu database system.  
A validated self-report questionnaire was used to measure physical activity [5]. 
Individuals were divided into the vigorously active group when they both exercised and 
engaged in demanding work activities whereas within the moderately active group the 
participants either exercised or carried out heavy physical work. The remainder of the study 
participants were separated into the sedentary group. 
 
SNP selection and Genotyping 
A strong association was identified between MC4R rs17782313 genetic variant and 
risk of obesity in a European population [12] which was then replicated in other populations 
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(13-15), including Asian Indians [16]. Strong associations have also been found between 
TCF7L2 SNPs (rs12255372 and rs7903146) and risk of T2D in a meta-analysis [17] in the 
Japanese population [35] as well as in Asian Indians [19, 20]. Although the TCF7L2 SNPs 
(rs12255372 and rs7903146) have showed significant linkage disequilibrium (r2=0.746), the 
rs7903146 variant has been shown to have the strongest effect in Caucasian populations [36, 
37]. Based on the previous studies, the above mentioned three SNPs were selected for the 
present study.  
Phenol-chloroform method was used to extract DNA from whole blood. The methodology for 
genotyping TCF7L2 rs12255372 (G/T) and rs7903146 (C/T) SNPs has been previously 
published [20]. Direct sequencing by an ABI 310 genetic analyzer (Applied Biosystems, 
Foster City, CA) helped to confirm the efficiency of the genotyping which was in 99% 
concordance based on random duplicates of 20% of the samples [20].  
MC4R rs17782313 (T/C) SNP: PCR volume (10 µl) consisted of 1X reaction buffer, 200 
mmol of dNTP, 1.5 mmol of MgCl2, 1 U taq DNA polymerase and 100 ng of genomic DNA. 
The concentrations for primers included 15 pmol of common primer, 15 pmol of allele 1 
primer and 1 pmol of allele 2 primer, equal to a 15:1 ratio of short primers to long primer. 
Cycles for PCR were carried out at 96°C for 12 min, then 35 cycles at 94°C for 30 sec, 
followed by 30 sec at 57°C, 30 sec at 72°C and finally for 10 min at 72°C . Electrophoresis 
was carried out with a 3% agarose gel.  
Inner Primers 
F: AAGTTTAAAGCAGGAGAGATTGTATACC (C allele 222bp) 
R: GCTTTTCTTGTCATTTCCAGCA (T allele 149bp) 
 Outer Primer: 
F: TTACTGATTTTAAGGGCATAAGCAA 
R: TATCATGCTGAGACAGGTTCATAAA (321bp) 
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Statistical Analyses 
Statistical analyses were carried out by using SPSS software (version 21). BMI ≥ 25 
kg/m2 was categorised as obese and BMI < 25 kg/m2 as non-obese. Descriptive statistics for 
continuous variables are shown as means and standard deviation (SD). Fasting serum insulin 
and triglyceride values were log transformed to obtain normal distribution. Genotype 
frequencies between cases and controls were compared by Chi Square test. The difference in 
the means of continuous variables between the genotypes was analysed by independent 
sample t test. Based on an additive model of analysis, dominant models were used for all 3 
single nucleotide polymorphisms (SNPs) where the common homozygous allele was 
compared to the combined heterozygous and rare homozygous alleles due to the low allele 
frequency of rare homozygotes. Association analyses between SNPs and continuous and 
categorical variables were carried out by linear and logistic regression models, respectively, 
adjusting for age, gender with the addition of BMI, when T2D was the outcome, and, 
adjusting for T2D, when obesity was the outcome. Linear and logistic regression models 
were also used for interaction analyses between SNPs and dietary factors (continuous 
variables) / physical activity (categorical variable) on continuous and categorical outcomes 
respectively, where the interaction terms were included into the models and were adjusted for 
age, gender, BMI, T2D and total energy intake when appropriate. Bonferroni correction for 
multiple testing was calculated by multiplying 3 SNPs with 14 outcomes (T2D, obesity, BMI, 
waist circumference, fasting blood glucose, HbA1c, fasting insulin, systolic and diastolic 
blood pressure, HDL, LDL, VLDL, TG and total cholesterol) and 4 dietary factors 
(carbohydrate, protein, fat, fibre) and physical activity level. The P value of 0.05 was then 
divided by 210 (3 SNPs x 14 outcomes x 5 lifestyle factors) which set the significant p value 
for all results at P= 0.00023.  
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As a secondary analysis, given the significant SNP-fat intake interaction, individuals 
were grouped into tertiles based on the fatty acid subtypes [monounsaturated (MUFA) and 
polyunsaturated (PUFA) fatty acids] for testing the interaction between SNPs and these fatty 
acid subtypes on lipids. In addition, PUFA was further stratified into ALA (alpha linolenic 
acid) and LA (linoleic acid) for the interaction analysis.  
Given that there are no previously reported effect sizes for the gene-diet interaction, 
we were unable to perform a prospective power calculation. However, based on the most 
significant interaction observed in the present study, we performed retrospective power 
calculations using QUANTO software, Version 1.2.4 (May 2009). We performed power 
calculations in the form of least detectable effects based on the assumption of significance 
levels and powers of 5 and 80 %, respectively. At 80% power, the minimum detectable 
effects ranged from beta 0.02 mg/dl (HDL-C) for a SNP with MAF of 5% to beta 1.0 mg/dl 
for a SNP with MAF 50% in the case-control analysis. For the TCF7L2 SNP – fat intake 
interaction on HDL-C (most significant interaction), the beta was 0.067, which is within the 
range of effect sizes for which the power was calculated. 
 
Results 
Phenotypic associations 
Based on the clinical and biochemical characteristics of the individuals from the 
CURES study as illustrated in Table 1, individuals with T2D were older (P<0.0001), had 
higher BMI (P<0.0001), waist circumference (P<0.0001), fasting plasma glucose (P<0.0001), 
HbA1c (P<0.0001), fasting plasma insulin (P<0.0001), systolic and diastolic blood pressure 
(P<0.0001), low density and very low density lipoproteins (P<0.0001), total cholesterol 
(P<0.0001), TG (P<0.0001) and lower high density lipoprotein (P=0.001) than NGT 
individuals.  
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 NGT T2D  P value* 
N 821 861  
(men/women) (345/476) (398/463) 0.08 
Age (yrs) 41.31±11.73 50.57±10.49 <0.0001 
BMI (kg/m2) 23.66±4.69 25.34±4.30 <0.0001 
WC (cm) 83.55±11.66 90.60±9.84 <0.0001 
FPG (mg/dl) 84.82±8.36 161.73±69.13 <0.0001 
HbA1c (%) 5.58±0.48 8.78±2.36 <0.0001 
INS (µIU/ml) 8.41±5.81 11.78±7.69 <0.0001 
Log INS (µIU/ml) 6.85±1.87 9.68±1.90 <0.0001 
Systolic BP (mmHg) 117.72±18.05 129.16±21.65 <0.0001 
Diastolic BP (mmHg) 74.06±11.32 76.76±11.85 <0.0001 
HDL (mg/dl) 43.36±9.91 41.71±9.50 0.001 
LDL (mg/dl) 113.13±30.55 124.49±35.38 <0.0001 
VLDL (mg/dl) 23.95±14.30 35.96±27.37 <0.0001 
TC (mg/dl) 180.02±36.02 199.51±42.40 <0.0001 
TG (mg/dl) 120.18±71.46 180.31±137.12 <0.0001 
Log TG (mg/dl) 105.68±1.62 152.75±1.71 <0.0001 
Total energy (Kcal/day) 2622.43±702.77 2468±893.75 <0.0001 
Total Carbohydrate (g) 419.69±112.33 399.96±147.98 0.002 
Fat (g) 68.57±24.29 64.25±27.31 0.001 
Total PUFA (g) 18.22±9.09 18.75±10.04 0.25 
Total MUFA (g) 20.51±7.77 18.79±8.37 <0.0001 
Protein (g) 73.82±20.97 69.93±24.56 0.001 
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Dietary fibre (g) 31.41±9.83 31.66±12.19 0.64 
Table 1: Anthropometric and biochemical characteristics of T2D and NGT participants.  
Data presented as Mean±SD. *P values are showing the differences in mean values between 
NGT and T2D participants. Abbreviations: NGT, normal glucose tolerance; BMI, Body mass 
index; WC, waist circumference; HbA1C, glycated haemoglobin; FPG, Fasting plasma 
glucose; INS, Fasting plasma insulin; HDL, high density lipoprotein; LDL, low density 
lipoprotein; VLDL, very low density lipoprotein; TC, Total Cholesterol; TG, triglycerides.  
 
Genetic associations 
The minor allele (‘T’) of SNPs (rs12255372 and rs7903146) of TCF7L2 gene showed 
significant susceptibility to T2D; however, in the present study after correction for multiple 
testing only the association between SNP rs7903146 and T2D remained statistically 
significant (P=0.0001) (S1 Table).After Bonferroni correction, statistically significant 
association between the ‘C’ allele of theMC4R SNP rs17782313 and T2D was also observed 
(P=0.00022) (S2 Table). None of the associations between the three SNPs and continuous 
variables remained significant after correction for multiple testing (P>0.00023) (S1 and S2 
Tables).  
 
TCF7L2 – dietary fat intake interactions on HDL-C  
Individuals were grouped into tertiles based on their fat and subtypes of fat intake 
(g/day). The means for fat intake in the 1st tertile: 41 g/d; 2nd tertile: 62 g/d; 3rd tertile: 95 g/d. 
Means for PUFA intake in the 1st tertile: 9g/d; 2nd tertile: 17 g/d; 3rd tertile: 29 g/d. Means for 
MUFA intake in the 1st tertile: 12 g/d; 2nd tertile: 18 g/d; 3rd tertile: 29 g/d. Means for ALA 
intake in the 1st tertile: 0.38 g/d; 2nd tertile: 0.58 g/d; 3rd tertile: 0.89 g/d. Means for LA intake 
in the 1st tertile: 8 g/d; 2nd tertile: 17 g/d; 3rd tertile: 29 g/d. 
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The interaction between the TCF7L2 SNP rs12255372 and fat intake (g/day) on HDL-
C was statistically significant after correction for multiple testing (Pinteraction=0.0001). The ‘T’ 
allele carriers of the TCF7L2 SNP rs12255372 had 2.26 mg/dl higher HDL-C level in the 
lowest tertile of fat intake (mean: 41 g/day) than the ‘GG’ homozygotes (P=0.008) and in the 
highest tertile of fat intake (mean: 95 g/day), HDL-C was 1.87 mg/dl lower in the risk ‘T’ 
allele carriers in comparison to the ‘GG’ homozygotes (p=0.017) (Fig 1).  
Stratification to fat subgroups showed significant interactions between the SNP 
rs12255372 and PUFA (g/day) on HDL-C (Pinteraction<0.0001), where the ‘T’ allele carriers 
had 1.96 mg/dl higher HDL-C (P= 0.024) in the low PUFA tertile (mean: 9 g/day) in 
comparison to the ‘GG’ homozygotes and in the 3rd tertile (mean: 29 g/day), the HDL-C level 
of the ‘T’ allele carriers was 1.64 mg/dl lower than the ‘GG’ homozygotes (P= 0.028) (Fig 
1).  A similar interaction was also found between the SNP rs12255372 and MUFA (g/day) on 
HDL-C (Pinteraction=0.0003), where the ‘T’ allele carriers had 1.77 (mg/dl) higher HDL-C in 
the lowest MUFA tertile (mean: 12 g/day) (P= 0.03) and had 1.61 (mg/dl) higher HDL-C in 
the 2nd tertile (mean: 18 g/day) (P= 0.045) than the ‘GG’ carriers, however in the highest 
MUFA tertile (mean: 29 g/day) the ‘T’ allele carriers had 1.59 (mg/dl) decreased HDL-C (P= 
0.041) than individuals with the ‘GG’ genotype. 
PUFA was further stratified to linoleic acid (LA) and alpha linolenic acid (ALA) to 
investigate whether omega-3 and omega-6 fatty acids modified the association between the 
TCF7L2 SNP rs12255372 and HDL-C. Significant interaction was found between the SNP 
and ALA on HDL-C (Pinteraction= 0.012), where the ‘T’ allele carriers had 2.42 (mg/dl) higher 
HDL-C than the ‘GG’ homozygotes (P= 0.004) in the lowest tertile (mean: 0.38 g/day) (Fig 
1).A similar interaction was also found between the SNP rs12255372 and LA (g/day) on 
HDL-C (Pinteraction<0.0001). S1 Table shows the interactions of TCF7L2 SNP rs12255372 
with fat, PUFA and ALA intakes on HDL-C under an additive and dominant model.    
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Additional gene-diet interactions 
In addition to the main significant findings, there was a significant interaction 
between TCF7L2 SNP  rs12255372 and fibre intake (g/day) on HDL-C (Pinteraction< 0.0001), 
where in the lowest tertile (mean: 20 g/day) individuals carrying the ‘T’ allele had 1.95 
(mg/dl) higher HDL-C (P=0.02), in the 2nd tertile (mean: 30 g/day), the ‘T’ allele carriers had 
2.39 (mg/dl) higher HDL-C (P= 0.003) and in the highest tertile (mean: 44 g/day), the HDL-
C level of the ‘T’ allele carriers was 2.37 mg/dl lower in comparison to the ‘GG’ 
homozygotes (P=0.002). There were several other interactions which did not reach statistical 
significance after correction for multiple testing and these interactions are shown in the Table 
2 and S2 and S3 Tables). 
rs12255372 SNP*Carbohydrate (g) SNP*Fibre (g) SNP*Protein (g) SNP*Fat (g) 
β ± SE  
(P for 
interaction on 
FPG) 
0.039 ± 0.019  
(0.041) 
0.437 ± 0.222 
(0.049) 
0.132 ± 0.108 
(0.222) 
0.119 ± 0.095 
(0.210) 
β ± SE  
(P for 
interaction on 
HDL-C) 
0.009 ± 0.003  
(0.007) 
0.168 ± 0.041 
(<0.0001) 
0.072 ± 0.020 
(0.0003) 
0.067 ± 0.017 
(0.00017) 
β ± SE 
(P for 
interaction on 
DBP) 
-0.003 ± 0.004  
(0.551) 
-0.107 ± 0.050 
(0.033) 
-0.028 ± 0.024  
(0.251) 
-0.032 ± 0.021 
(0.130) 
rs7903146 SNP*Carbohydrate (g) SNP*Fibre (g) SNP*Protein (g) SNP*Fat (g) 
β ± SE  
(P¥ for 
interaction on 
T2D) 
0.002 ± 0.001  
(0.011) 
0.014 ± 0.010  
(0.180) 
0.011 ± 0.005  
(0.024) 
0.008 ± 0.004  
(0.071) 
β ± SE  
(P for 
interaction on 
HDL-C) 
0.006 ± 0.003  
(0.057) 
0.128 ± 0.040  
(0.002) 
0.050 ± 0.020  
(0.010) 
0.052 ± 0.017  
(0.003) 
 
Table 2: Interactions of TCF7L2 SNPs rs12255372 and rs7903146 with carbohydrate, fibre 
and protein intake on HDL-C, fasting blood glucose and diastolic blood pressure. *Interaction 
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term; **P values are adjusted for age, gender, BMI, T2D and Total energy intake. ¥ P values 
are adjusted for age, gender, BMI and Total energy intake. Abbreviations: SNP, Single 
nucleotide polymorphism; HDL-C, High density lipoprotein cholesterol; FPG, Fasting 
plasma glucose; DBP, Diastolic blood pressure. 
 
 
Gene-physical activity interactions on cardio-metabolic traits 
No statistically significant interactions were observed after correction for multiple testing 
between the three SNPs and physical activity on obesity- and T2D- related traits 
(Pinteraction>0.0002). Interactions observed between TCF7L2 SNP rs7903146 and physical 
activity on VLDL (Pinteraction= 0.012) and TG (Pinteraction= 0.014), where the risk ‘T’ allele 
carriers had higher TG and VLDL levels, did not reach statistical significance after correction 
for multiple testing (S4 Table).  
 
Discussion 
This is the first study to investigate interactions between TCF7L2 and MC4R SNPs 
and lifestyle factors on cardio-metabolic traits among Asian Indians. The main findings 
suggest that total fat and PUFA intakes may modify the association between the TCF7L2 
SNP rs12255372 and HDL-C. In the lowest total fat and PUFA tertiles, participants carrying 
the ‘XT’ genotype (GT+TT) had significantly higher HDL-C, whereas in the highest tertile 
participants carrying the ‘XT’ genotype had lower HDL-C, as compared to those with the GG 
genotype. This finding is of public health significance given that Asian Indians tend to have 
low HDL-C which puts them at markedly increased risk for CVD [38, 39].   
The fat intake consists of invisible, hidden and visible fat (vegetable oils, ghee, butter) 
in India where in the urban areas the minimum average daily intake of visible fat is 
 
 
17 
 
approximately 22–45 g/day [40]. The recommended omega 3 PUFA intake is 0.1 gram/day, 
however the median of combined intake of LA and ALA is 13 g/day and the recommended 
ratio between LA and ALA is  5:1 to 10:1 [40]. In comparison, the results of our study 
suggest that total fat intake below 53 g/day, PUFA intake below 13 g/day, and ALA intake 
below 0.49 g/day may help maintain high levels of HDL-C in the ‘T’ allele carriers of the 
TCF7L2 SNP rs12255372. The findings that MUFA intake above 22 g/day reduces HDL-C 
and only ALA intake below 0.5 g/day maintains high HDL-C level in risk carriers are 
unexpected results; however, the effect of polygenic traits cannot be ruled out.  
HDL-C is generally considered to be protective against CVD due to its role in the 
reverse cholesterol transport; however, the recent Mendelian randomization (MR) studies [41, 
42] have failed to show a causal effect of low HDL-C on cardiovascular disease risk. But, 
none of these MR studies have taken dietary factors into account. Furthermore,  fatty acids 
have shown to have different modulating effect on HDL-C for which the mechanism is not 
fully understood [43]. On the other hand, it is argued that the total fat intake is more 
influential on postprandial lipoprotein abnormalities, which is a characteristic of T2D, than 
the type of fatty acids [44]. However, studies have also shown that different fatty acids can 
have differential effects on postprandial TG [45-47]. In our study, we found that those in the 
lowest fat intake subgroups had higher HDL-C while those in the highest tertile groups had 
lower HDL-C among the risk allele carriers. A previous intervention study in the US 
population [30] also found significant interaction between SNP rs12255372 and fat intake 
where positive changes in body composition were observed in the ‘T’ risk allele carriers only 
on the low-fat diet (20% from total energy). Other studies only reported significant 
interactions between SNP rs7903146 and high saturated fat intake on increased metabolic 
syndrome risk [29] and high (n-6) PUFA intake (≥6.62% of energy intake) on increased 
VLDL and TG [24] among the risk ‘T’ allele carriers.  
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High omega 6 to omega 3 ratio has been shown to increase HDL in mice [43], 
whereas the results from this study in humans contradict those findings. It has been shown in 
cell and animal studies that high omega 6 PUFA intake is pro-inflammatory leading to an 
increased risk for CVD and diabetes [48] and in the present study reduced HDL was observed 
in the minor allele carriers in response to high intake of omega 6 PUFA (>21.6 g/d). 
According to our findings, a low omega 6 (<12.8 g/d) and a low ALA intake (<0.5 g/d) may 
help maintain HDL above 44 (mg/dl) in the risk allele carriers. 
Though there was no significant difference in mean HDL levels in the different 
tertiles of total fat and PUFA intakes in the study participants (data not shown), in the 
presence of TCF7L2 rs12255372 genotype, a clear interaction between the genotype and fat/ 
PUFA intake on HDL-C was observed. While the carriers of ‘XT’ genotype had increased 
HDL-C in the presence of a low fat/ low PUFA diet, there was a decrease in HDL-C levels in 
the carriers of ‘XT’ genotype in the presence of a high fat / high PUFA diet. It is to be noted 
that among those who carry the GG genotype, irrespective of the dietary fat/PUFA intake, 
there is no effect on HDL-C levels.  
Another interesting interaction was the one between TCF7L2 SNP rs12255372 and 
fibre intake on HDL-C. The results suggest that low and medium fibre intake (means: 20, 30 
g/day), respectively, increase HDL-C whereas high fibre intake (mean: 44 g/day) may reduce 
HDL-C among risk allele carriers of the TCF7L2 SNP rs12255372. The average fibre intake 
in India is 30-40 g/day [40] which is consistent with the mean intake in the medium and high 
tertiles and also higher compared to the mean fibre intake in the UK (~18g/day) and the US 
(~16g/day). A previous study investigated interaction between SNP rs7903146 and fibre 
intake on T2D risk [28],where the minor allele carriers had increased T2D risk with higher 
fibre intake (mean intake: 13.1 ± 2.2 g/4,184 kJ). High fibre intake is generally recommended 
to improve glycemic control in T2D individuals [49] and to reduce total and LDL-C in order 
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to reduce CVD risk. A meta-analysis of data from clinical studies (n=2,990) [50] indicated 
that high fibre diets (20-30 g/day) reduced HDL-C. Similarly, another meta-analysis of data 
from 24 clinical studies also suggested that medium and high carbohydrate, high fibre (≥20 
g/day) diets also decreased HDL by 4% [51].However, it was argued, that the decrease in 
LDL-C and TG values would reduce CVD risk by 16.4% which would outweigh the 
increased risk of CVD by 11.9% due to decreased HDL [51]. But it is of note that these meta-
analyses did not consider the genetic component and, furthermore, we also observed gene-
diet interaction on other lipid outcomes such as VLDL and TG, which did not remain 
significant after correction for multiple testing.  
The risk of coronary artery disease is increased in individuals with circulating HDL-C 
concentration of <40 mg/dl [52]. In our study, within the high fibre intake tertile (≥35g/day), 
the mean HDL-C level of the minor risk allele carriers was 39.46 mg/dL in comparison to 
42.27 mg/dl of the ‘GG’ carriers of the TCF7L2 SNP rs12255372. The results of our study 
suggest that high fibre intake (35 – 102 g/day) may help maintain HDL-C level above 40 
mg/dl whereas below 35 g/day may lower HDL-C in the ’GG’ genotype carriers of SNP 
rs12255372. Mechanisms on how low/high fibre intake decreases/increases HDL-C are not 
well understood and more research is needed to clarify the effects of dietary fibre on HDL-C 
metabolism [52, 53].  
No studies, to date, have investigated interactions between the TCF7L2 SNPs 
(rs12255372 and rs7903146) and MC4R SNP rs17782313 and physical activity on cardio-
metabolic traits in Asian Indians. Despite the fact that the majority of people are physically 
inactive in India [54], no significant interactions were found after correction for multiple 
testing between the three polymorphisms and physical activity on cardio-metabolic traits, 
which could be due to a small sample size and measurement bias associated with self-
reported physical activity questionnaire. However, our finding is in support of the previous 
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study in a Spanish population [21] with a much larger sample size (n=7,052) which also did 
not find a significant interaction between MC4R SNP rs17782313 and physical activity on 
obesity traits. Though the inclusion of a representative sample of Chennai for analysis and the 
use of a comprehensive, validated, interviewer administered semi-quantitative FFQ for 
dietary assessment could be considered the strengths of this study, there are some underlying 
limitations. The data used to calculate the measures of dietary intake and physical activity 
came from self-report and hence, measurement bias associated with self-reported 
questionnaire cannot be ruled out. Given that obesity and diabetes are multifactorial traits, 
several genetic and lifestyle factors are likely to contribute to the disease. While 97 loci have 
been shown to be associated with body weight [55], the present study examined only three 
common variants, given their consistent associations with obesity and diabetes, respectively, 
in Europeans and Asian Indians. The cross sectional study design gives only a snapshot of the 
prevalence and cause - effect cannot be established due to lack of follow up which is another 
limitation of this study. However, several outcomes and risk factors were assessed and there 
was no loss to follow up.  
In conclusion, this study has found significant interactions between the TCF7L2 SNP 
rs12255372 and dietary factors on HDL-C in this Asian Indian population. The results of this 
study indicate that high total fat and PUFA intakes may be associated with lower HDL-C 
whereas low intake is associated with higher HDL among the risk allele carriers. More 
research is required to better understand the interactions between the TCF7L2 gene variant 
and lifestyle factors on cardio-metabolic traits. Exact mechanisms identifying the effect of 
different fatty acids on HDL-C and whether/how high fat- and PUFA- intake may reduce 
HDL-C should also be established before public health recommendations and personalised 
nutrition advice can be developed for this Asian Indian population in order to reduce the 
burden of cardiometabolic diseases.  
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Figure legends 
 
Fig 1.Interaction of the TCF7L2 gene polymorphism (rs12255372) with fat (g) intake, PUFA 
intake and Alpha Linolenic Acid (g) intake on HDL-C. Individuals carrying the ‘XT’ 
genotype had 2.26 mg/dl higher HDL-C in the lowest fat tertile (P= 0.008), while those in the 
highest tertile had 1.87 mg/dl lower HDL-C (P= 0.017) than those who carry the ‘GG’ allele. 
Carriers of the ‘XT’ genotype had 1.96 mg/dl higher HDL-C in the 1st tertile of PUFA intake 
(g) (P= 0.024), while those in the 3rd tertile had 1.64 mg/dl lower HDL-C in comparison to 
the carriers of the ‘GG’ genotype (P= 0.028). In the 1st tertile of Alpha Linolenic acid intake 
(g), individuals with the ‘XT’ genotype had 2.42 mg/dl higher HDL-C than the ‘GG’ 
homozygotes (P= 0.004). 
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